Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone

Mao, Z., Valluru, M.K. orcid.org/0000-0001-9156-866X and Ong, A.C.M. orcid.org/0000-0002-7211-5400 (2021) Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone. Clinical Kidney Journal. sfab062. ISSN 2048-8505

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: ADPKD; clinical trial; diabetes mellitus; magnetic resonance imaging; polycystic kidney disease
Dates:
  • Accepted: 12 March 2021
  • Published (online): 26 March 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 15 Apr 2021 10:55
Last Modified: 11 May 2021 16:44
Status: Published online
Publisher: Oxford University Press
Refereed: Yes
Identification Number: https://doi.org/10.1093/ckj/sfab062

Download

Share / Export

Statistics